Iterum Therapeutics Plc (ITRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,002 | 13,026 | 12,652 | 24,125 | 13,406 |
| Marketable Securities | N/A | N/A | N/A | N/A | 1,096 |
| Receivables | 448 | N/A | N/A | 48 | 208 |
| Inventories | 1,149 | 948 | 533 | N/A | N/A |
| TOTAL | $13,727 | $14,890 | $13,513 | $24,787 | $15,854 |
| Non-Current Assets | |||||
| PPE Net | 18 | 12 | 18 | 23 | 30 |
| Intangibles | 18,710 | 19,059 | 19,404 | 19,746 | 0 |
| Other Non-Current Assets | 48 | 53 | 40 | 39 | 40 |
| TOTAL | $18,776 | $19,124 | $19,462 | $19,808 | $70 |
| Total Assets | $32,503 | $34,014 | $32,975 | $44,595 | $15,924 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 577 | 1,189 | 413 | 251 | 835 |
| Accrued Expenses | 5,216 | 3,951 | 2,878 | 2,651 | 3,492 |
| Other current liabilities | 332 | 197 | 325 | 14,703 | 14,376 |
| TOTAL | $6,430 | $5,533 | $3,628 | $17,605 | $18,703 |
| Non-Current Liabilities | |||||
| Long Term Debt | 21,215 | 20,653 | 20,705 | 20,300 | N/A |
| Other Non-Current Liabilities | 12,239 | 11,715 | 11,196 | 10,771 | 8,728 |
| TOTAL | $33,454 | $32,368 | $31,901 | $31,071 | $8,728 |
| Total Liabilities | $39,884 | $37,901 | $35,529 | $48,676 | $27,431 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 52,788 | 44,657 | 40,000 | 34,581 | 27,516 |
| Common Shares | 490 | 421 | 357 | 315 | 227 |
| Retained earnings | -506,451 | -497,472 | -490,963 | -486,072 | -479,490 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 2 |
| TOTAL | $-7,381 | $-3,887 | $-2,554 | $-4,081 | $-11,507 |
| Total Liabilities And Equity | $32,503 | $34,014 | $32,975 | $44,595 | $15,924 |